Controller medications, also known as daily maintenance medications, are a critical tool for managing asthma — reducing daily ...
The South San Francisco, Calif., biopharmaceutical company in May shut down two trials of zelnecirnon, which was being evaluated as a treatment for asthma and atopic dermatitis.
Shares of RAPT Therapeutics (RAPT) plunged 46% Monday after the company said it was scrapping development of its drug ...
At the recent American College of Allergy, Asthma & Immunology (ACAAI) annual meeting, experts discussed the evolving concept ...
Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics ...
Asthma in early childhood could be linked to memory deficits, according to a new UC Davis study ... Research with rodents has ...
Youngsters with the condition performed worse at memory tasks in a study that followed 500 participants for two years ...